Article
The microRNA, miR-133b, functions to slow Duchenne muscular dystrophy pathogenesis
2020-03-20
Abstract excerpt
Duchenne muscular dystrophy (DMD) is characterized by progressive degeneration of skeletal muscles. To date, there are no treatments available to slow or prevent the disease. Hence, it remains essential to identify molecular factors that promote muscle biogenesis since they could serve as therapeutic targets for treating DMD. While the muscle enriched microRNA, miR-133b, has been implicated in the biogenesis of mu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 416bbcbc-0035-5fae-bec0-a0b5f4f9c868
- DOI
- 10.1101/2020.03.19.988519
